{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:22:15Z","timestamp":1794432135984,"version":"4.9.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Second primary cancer (SPC) after primary colorectal cancer (CRC), emerges as a novel challenge for cancer prevention with pronounced differences between female and male patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was a retrospective study of 140\u2009907 CRC survivors from the surveillance, epidemiology, and end results program database. Competing risk models and nomograms were constructed to predict the risk of SPCs, which were assessed with the C-Index, calibration and decision curve analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The 10-year cumulative incidence of SPC was higher in male than in female CRC survivors. The top five common SPCs in female CRC survivors were colorectal, breast, lung and bronchus, corpus and uterus and pancreatic cancers, while in male were prostate, colorectal, lung and bronchus, urinary cancer and melanoma of the skin. Breast and prostate were the most common sites for the development of SPCs after CRC. Older age, stage I and surgery were common risk factors for SPCs in both female and male. The nomogram for predicting the risk of developing SPC-breast cancer in female patients included age, race, site, histology grade, surgery, chemotherapy and stage. However, the model of predicting SPC-prostate cancer in male patients included age, race, site, size, surgery, chemotherapy, radiation and stage. Notably, the nomograms were validated to have a precise discriminative ability, accuracy and clinical effectiveness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The study surveyed the characteristics of CRC survivors with a particular focus on the incidence of SPC. The models could help supervise the development of a second breast or prostate cancer in female or male CRC survivors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000731","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:08:42Z","timestamp":1641514122000},"page":"430-441","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["The incidence of second primary cancer in male and female patients with initial colorectal cancer: a SEER population-based study"],"prefix":"10.1097","volume":"31","author":[{"given":"Yanyan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Nanjing Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Nanjing Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongbo","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University"},{"name":"Department of Medical Oncology, Jinling Hospital, Nanjing Medical University"},{"name":"Department of Medical Oncology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjie","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University"},{"name":"Department of Medical Oncology, Jinling Hospital, Nanjing Medical University"},{"name":"Department of Medical Oncology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/pon.4299","article-title":"Examining the relationship between multiple primary cancers and psychological distress: a review of current literature.","volume":"26","author":"Belcher","year":"2017","journal-title":"Psychooncology"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/1471-2407-11-438","article-title":"Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival.","volume":"11","author":"Birgisson","year":"2011","journal-title":"BMC Cancer"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(18)30903-3","article-title":"Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.","volume":"20","author":"Bright","year":"2019","journal-title":"Lancet Oncol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1245\/s10434-019-07326-7","article-title":"Sidedness of colorectal cancer impacts risk of second primary gastrointestinal malignancy.","volume":"26","author":"Broman","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"728","DOI":"10.5009\/gnl16526","article-title":"Assessment of the risk of colorectal cancer survivors developing a second primary pancreatic cancer.","volume":"11","author":"Chung","year":"2017","journal-title":"Gut Liver"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1572-0241.2006.00580.x","article-title":"Temporal trend in relative risk of second primary colorectal cancer.","volume":"101","author":"Das","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1200\/JCO.1985.3.12.1640","article-title":"Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.","volume":"3","author":"Fisher","year":"1985","journal-title":"J Clin Oncol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/a-1041-2945","article-title":"How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: a predictive model.","volume":"52","author":"Frazzoni","year":"2020","journal-title":"Endoscopy"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cam4.1437","article-title":"Excessive risk of second primary cancers in young-onset colorectal cancer survivors.","volume":"7","author":"He","year":"2018","journal-title":"Cancer Med"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"e644","DOI":"10.1634\/theoncologist.2019-0266","article-title":"Second primary malignancies in patients with colorectal cancer: a population-based analysis.","volume":"25","author":"Jia","year":"2020","journal-title":"Oncologist"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.coc.0000258084.55036.9e","article-title":"A population-based analysis of second primary cancers after irradiation for rectal cancer.","volume":"30","author":"Kendal","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijrobp.2005.11.013","article-title":"Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer.","volume":"65","author":"Kendal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"241","DOI":"10.15430\/JCP.2017.22.4.241","article-title":"Secondary primary prostate cancer after colorectal cancer: a nationwide population-based cohort study in Korea.","volume":"22","author":"Kim","year":"2017","journal-title":"J Cancer Prev"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamasurg.2014.3572","article-title":"Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains.","volume":"150","author":"Kneuertz","year":"2015","journal-title":"JAMA Surg"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data.","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00423-009-0553-1","article-title":"Multiple primary malignancies involving colorectal cancer \u2013 clinical characteristics and prognosis with reference to surveillance.","volume":"395","author":"Lee","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"e1079","DOI":"10.1097\/MD.0000000000001079","article-title":"Incidence of second primary malignancies following colorectal cancer: a distinct pattern of occurrence between colon and rectal cancers and association of co-morbidity with second primary malignancies in a population-based cohort of 98,876 patients in Taiwan.","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jjco\/hyv137","article-title":"Young patients with colorectal cancer have increased risk of second primary cancers.","volume":"45","author":"Liang","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/DCR.0b013e318279eb30","article-title":"Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer.","volume":"56","author":"Liu","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","article-title":"Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.","volume":"110","author":"Murray","year":"2014","journal-title":"Radiother Oncol"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2468-1253(19)30345-0","article-title":"The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"4","author":"Safiri","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma.","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/DCR.0000000000001203","article-title":"Secondary breast, ovarian, and uterine cancers after colorectal cancer: a nationwide population-based cohort study in Korea.","volume":"61","author":"Shin","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020.","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020.","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1186\/s12885-018-4823-6","article-title":"Second primary colorectal cancer after the initial primary colorectal cancer.","volume":"18","author":"Yang","year":"2018","journal-title":"BMC Cancer"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4143\/crt.2008.40.2.71","article-title":"Clinical characteristics of multiple primary colorectal cancers.","volume":"40","author":"Yoon","year":"2008","journal-title":"Cancer Res Treat"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10620-016-4362-4","article-title":"Epidemiological trends in colorectal cancer in China: an ecological study.","volume":"62","author":"Zhu","year":"2017","journal-title":"Dig Dis Sci"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:02:18Z","timestamp":1748361738000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000731","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,5]]}}}